Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Accumulated Expenses (2021 - 2025)

Historic Accumulated Expenses for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $311184.0.

  • HeartSciences' Accumulated Expenses fell 1582.18% to $311184.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $311184.0, marking a year-over-year decrease of 1582.18%. This contributed to the annual value of $506307.0 for FY2025, which is 2710.71% up from last year.
  • As of Q4 2025, HeartSciences' Accumulated Expenses stood at $311184.0, which was down 1582.18% from $599287.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Accumulated Expenses ranged from a high of $1.1 million in Q2 2022 and a low of $288927.0 during Q2 2021
  • Its 5-year average for Accumulated Expenses is $536817.3, with a median of $505927.0 in 2022.
  • As far as peak fluctuations go, HeartSciences' Accumulated Expenses soared by 26467.2% in 2022, and later crashed by 6337.85% in 2023.
  • HeartSciences' Accumulated Expenses (Quarter) stood at $288927.0 in 2021, then surged by 208.26% to $890654.0 in 2022, then fell by 13.25% to $772670.0 in 2023, then tumbled by 52.16% to $369673.0 in 2024, then dropped by 15.82% to $311184.0 in 2025.
  • Its last three reported values are $311184.0 in Q4 2025, $599287.0 for Q3 2025, and $506307.0 during Q2 2025.